Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
| Autor: | Lidan, Jin, Wenhe, Zhao, Jun, Zhang, Wenjun, Chen, Tan, Xie, Linbo, Wang, Wanhung, Fan, Shuduo, Xie, Jianguo, Shen, Heming, Zheng, Wenxian, Hu, Qun, Wei, Minjun, Dong, Qinchun, Wang, Jun, Shen, Yongcheng, Liu |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Adolescent Biopsy Breast Neoplasms Cell Count Cell Separation circulating tumor cells Diagnosis Differential Young Adult breast cancer Cell Line Tumor Humans Breast Early Detection of Cancer Mastectomy Aged Neoplasm Staging Original Research cancer staging screening Clinical Cancer Research Middle Aged Neoplastic Cells Circulating Healthy Volunteers ROC Curve Case-Control Studies Feasibility Studies Female early diagnosis |
| Zdroj: | Cancer Medicine |
| ISSN: | 2045-7634 |
| Popis: | Purpose In this study, we aimed to investigate the viability of utilizing CytoSorter® system to detect circulating tumor cells (CTCs) and to evaluate the diagnostic value of CTCs in breast cancer (BC). Methods A total of 366 females patients suspected of having BC and 30 healthy female volunteers were enrolled in this study. CTCs were enriched by CytoSorter®, a microfluidic‐based CTCs capturing platform. CTC detection was performed before operation or biopsy. Based on the biopsy results, patients were divided into two groups, namely patients with BC and patients with benign breast diseases (BBD). Patients with BBD and healthy volunteers were serving as controls. The correlation between CTC enumeration and patients' clinicopathological characteristics was evaluated. The receiver operating characteristic (ROC) curve was plotted to assess the diagnostic potency of CytoSorter® system in BC. Results Based on the biopsy results, 130 BC patients at different cancer stages and 236 patients with BBD were enrolled in the study. Seven subjects were dropped out from the study. CTCs were detected in 109 of 128 BC patients, in one of 29 healthy volunteers, and in 37 of 232 patients with BBD. Maximum CTC counts detected in BC patients, healthy volunteers, and patients with BBD were 8, 1, and 4, respectively. Statistical analysis showed CTCs could be used to distinguish BC patients from healthy volunteers and patients with BBD (P Circulating tumor cells were successfully isolated in breast cancer (BC) patients using CytoSorter® system. Circulating tumor cells can be used to differentiate BC patients from the patients with benign breast diseases or healthy volunteers, and as a diagnostic aid for early cancer diagnosis and cancer staging. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text